These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 9706136

  • 21. Functional and histological differences in autogenous and allogenic vein grafts: two different vasculopathies?
    Davies MG, Dalen H, Svendsen E, Hagen PO.
    J Surg Res; 1997 Apr; 69(1):14-22. PubMed ID: 9202641
    [Abstract] [Full Text] [Related]

  • 22. External support modulates G protein expression and receptor coupling in experimental vein grafts.
    Huynh TT, Iaccarino G, Davies MG, Safi HJ, Koch WJ, Hagen PO.
    Surgery; 1999 Aug; 126(2):127-34. PubMed ID: 10455874
    [Abstract] [Full Text] [Related]

  • 23. Influence of perioperative catheter injury on the long-term vein graft function and morphology.
    Davies MG, Dalen H, Svendsen E, Hagen PO.
    J Surg Res; 1996 Dec; 66(2):109-14. PubMed ID: 9024820
    [Abstract] [Full Text] [Related]

  • 24. G beta gamma-mediated signaling: new therapeutic target for proliferative vascular disease.
    Iaccarino G, Koch WJ.
    IUBMB Life; 1999 Sep; 48(3):257-61. PubMed ID: 10690635
    [Abstract] [Full Text] [Related]

  • 25. Efficient adenoviral gene transfer to early venous bypass grafts: comparison with native vessels.
    Channon KM, Fulton GJ, Gray JL, Annex BH, Shetty GA, Blazing MA, Peters KG, Hagen PO, George SE.
    Cardiovasc Res; 1997 Sep; 35(3):505-13. PubMed ID: 9415295
    [Abstract] [Full Text] [Related]

  • 26. Topical mitogen-activated protein kinases inhibition reduces intimal hyperplasia in arterialized vein grafts.
    Gulkarov I, Bohmann K, Cinnante KM, Pirelli L, Yu PJ, Grau JB, Pintucci G, Galloway AC, Mignatti P.
    J Surg Res; 2009 Jun 01; 154(1):150-6. PubMed ID: 18805551
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Responsiveness of vein bypass grafts to stimulation with norepinephrine and 5-hydroxytryptamine.
    Makhoul RG, Davis WS, Mikat EM, McCann RL, Hagen PO.
    J Vasc Surg; 1987 Jul 01; 6(1):32-8. PubMed ID: 3599278
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effect of gene delivery of NOS isoforms on intimal hyperplasia and endothelial regeneration after balloon injury.
    Cooney R, Hynes SO, Sharif F, Howard L, O'Brien T.
    Gene Ther; 2007 Mar 01; 14(5):396-404. PubMed ID: 17080182
    [Abstract] [Full Text] [Related]

  • 32. The reversibility of canine vein-graft arterialization.
    Fann JI, Sokoloff MH, Sarris GE, Yun KL, Kosek JC, Miller DC.
    Circulation; 1990 Nov 01; 82(5 Suppl):IV9-18. PubMed ID: 2225440
    [Abstract] [Full Text] [Related]

  • 33. All-trans-retinoic acid decreases cell proliferation and increases apoptosis in an animal model of vein bypass grafting.
    Leville CD, Osipov VO, Jean-Claude JM, Seabrook GR, Towne JB, Cambria RA.
    Surgery; 2000 Aug 01; 128(2):178-84. PubMed ID: 10922989
    [Abstract] [Full Text] [Related]

  • 34. Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation.
    Tatewaki H, Egashira K, Kimura S, Nishida T, Morita S, Tominaga R.
    J Vasc Surg; 2007 Jun 01; 45(6):1236-43. PubMed ID: 17543688
    [Abstract] [Full Text] [Related]

  • 35. Regression of intimal hyperplasia with restoration of endothelium-dependent relaxing factor-mediated relaxation in experimental vein grafts.
    Davies MG, Klyachkin ML, Dalen H, Svendsen E, Hagen PO.
    Surgery; 1993 Aug 01; 114(2):258-70; discussion 270-1. PubMed ID: 8342130
    [Abstract] [Full Text] [Related]

  • 36. Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy.
    Ehsan A, Mann MJ, Dell'Acqua G, Dzau VJ.
    J Thorac Cardiovasc Surg; 2001 Apr 01; 121(4):714-22. PubMed ID: 11279413
    [Abstract] [Full Text] [Related]

  • 37. Systemic hypertension and hypercholesterolemia in vein grafts: effects on the function and morphology of experimental vein grafts.
    Davies MG, Kim JH, Barber L, Dalen H, Svendsen E, Hagen PO.
    J Surg Res; 1994 Jul 01; 57(1):106-21. PubMed ID: 8041125
    [Abstract] [Full Text] [Related]

  • 38. G protein signaling and vein graft intimal hyperplasia: reduction of intimal hyperplasia in vein grafts by a Gbetagamma inhibitor suggests a major role of G protein signaling in lesion development.
    Davies MG, Huynh TT, Fulton GJ, Lefkowitz RJ, Svendsen E, Hagen PO, Koch WJ.
    Arterioscler Thromb Vasc Biol; 1998 Aug 01; 18(8):1275-80. PubMed ID: 9714134
    [Abstract] [Full Text] [Related]

  • 39. Effects of vaccinia virus anti-inflammatory protein 35K and TIMP-1 gene transfers on vein graft stenosis in rabbits.
    Puhakka HL, Turunen P, Gruchala M, Bursill C, Heikura T, Vajanto I, Greaves DR, Channons K, Ylä-Herttuala S.
    In Vivo; 2005 Aug 01; 19(3):515-21. PubMed ID: 15875770
    [Abstract] [Full Text] [Related]

  • 40. Angiotensin II and tumor necrosis factor-alpha upregulate survivin and Kruppel-like factor 5 in smooth muscle cells: Potential relevance to vein graft hyperplasia.
    Bafford R, Sui XX, Wang G, Conte M.
    Surgery; 2006 Aug 01; 140(2):289-96. PubMed ID: 16904982
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.